Assure-Csu: Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

BACKGROUND Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H1-antihistamines. So far, the humanistic, societal and economic burden of CSU/CIU has not been well quantified. ...

متن کامل

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU

BACKGROUND Chronic spontaneous urticaria (CSU) can be debilitating, difficult to treat, and frustrating for patients and physicians. Real-world evidence for the burden of CSU is limited. The objective of this study was to document disease duration, treatment history, and disease activity, as well as impact on health-related quality of life (HRQoL) and work among patients with inadequately contr...

متن کامل

Psychological status in patients with chronic urticaria

 Abstract Background: Chronic urticaria (CU) is a common dermatological disease that induces a substantial burden on individuals’ life. Also if one’s self-image changes (which usually happen in patients with dermatological diseases), it leads to anxiety or other various symptoms. We aimed to compare the psychological scales in patients with CU with non-dermatological individuals with the purpos...

متن کامل

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases

Background Chronic spontaneous urticaria (CSU) is more common in adults, especially middle-aged women. The condition resolves spontaneously within 6 months in 30 to 55% of patients but can persist for years in others. It has a devastating effect on the quality of life of those who experience it. Although the mechanisms are not fully elucidated, anti IgE recombinant humanized monoclonal (Omalizu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2016

ISSN: 1098-3015

DOI: 10.1016/j.jval.2016.09.1538